There is 1 paper on GAL3+ disease-associated microglia abundance in aging research: none in people yet, 1 in animals.
1 paper studies it2 findings
See all 1 papers on GAL3+ disease-associated microglia abundance
- Animals1
Upstream
2BCL2
upin mice1
1 study
BCL2
upin mice1
BCL2 increases GAL3+ disease-associated microglia abundance in mice (shown by pharmacological targeting of BCL2).
“Pharmacogenetic or pharmacological targeting of p16ink4a or BCL2 reduced white matter GAL3+ DAM abundance and rejuvenated microglial fimbria organization.”
Animalsshown by pharmacological targeting of BCL2white matter
Senescent and disease-associated microglia are modifiable features of aged brain white matter
Research squarePreprint
CDKN2A
upin mice1
1 study
CDKN2A
upin mice1
CDKN2A increases GAL3+ disease-associated microglia abundance in mice (shown by pharmacogenetic targeting of p16ink4a).
“Pharmacogenetic or pharmacological targeting of p16ink4a or BCL2 reduced white matter GAL3+ DAM abundance and rejuvenated microglial fimbria organization.”
Animalsshown by pharmacogenetic targeting of p16ink4awhite matter
Senescent and disease-associated microglia are modifiable features of aged brain white matter
Research squarePreprint